Management of Medication-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients With Pentoxifylline and Tocopherol: Case Reports

Management of Medication-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients With Pentoxifylline and Tocopherol: Case Reports

Medication-related osteonecrosis of the jaw (MRONJ) is a well-known side effect of bone-modifying agents such as antiresorptive medications including pamidronic and zoledronic acids (intravenous bisphosphonates) and denosumab (anti-RANK ligand humanized monoclonal antibody). The major risk factor fo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Adepitan A. Owosho, Katherine A. DeColibus, Layne C. Levy, Osariemen Okhuaihesuyi
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Case Reports in Dentistry
Online Access:	http://dx.doi.org/10.1155/crid/2765925
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
by: Pelagia I. Melea, et al.
Published: (2014-01-01)

Concomitant Factors Leading to an Atypical Osteonecrosis of the Jaw in a Patient with Multiple Myeloma
by: Jaume Miranda-Rius, et al.
Published: (2014-01-01)

Radiologic and Pathologic Insights into Medication-Related Osteonecrosis of the Jaw in Myeloma Patients: A Report of 3 Cases
by: Suvarna Indermun, BDS, PgDip, MSc, et al.
Published: (2025-10-01)

Physicians' awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis.
by: Nachapol Supanumpar, et al.
Published: (2024-01-01)

Panoramic Radiography Features of Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Rossana Izzetti, et al.
Published: (2023-01-01)

Bisphosphonate-related osteonecrosis of the jaw: An enigma among medical practitioners
by: Shalini Krishnan, et al.
Published: (2019-01-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)

Research progress on the at-risk category and stage 0 of medication-related osteonecrosis of the jaw
by: YANG Mu, et al.
Published: (2025-02-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis
by: Geetika Bhatt, et al.
Published: (2014-01-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Medication-Related Osteonecrosis of the Jaw: A Case Report of an Unusual Side Effect of Adalimumab
by: Laura Sisalli, et al.
Published: (2023-01-01)

Omega-3 attenuates the severity of medication-related osteonecrosis of the jaws in rats treated with zoledronate.
by: Juliano Milanezi de Almeida, et al.
Published: (2025-01-01)

Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01)

Experimental study of the effect of teriparatide on a medication-related rat model of osteonecrosis of the jaw
by: LIAO Chenyu, et al.
Published: (2024-02-01)

Medication-related osteonecrosis of the jaws: a series of 22 cases highlighting their histopathological features
by: Dandara Andrade de SANTANA, et al.
Published: (2025-06-01)

Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients
by: Salman Ali Alabdali, et al.
Published: (2024-12-01)

Dental Hygienists’ Awareness of Medication-Related Osteonecrosis of the Jaw in Private Dental Clinics in Japan
by: Yosuke Iijima DDS, PhD, et al.
Published: (2024-10-01)

Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
by: E. M. Spevak, et al.
Published: (2022-07-01)

Occlusive denture for the management of medication-related osteonecrosis of the jaw with oronasal communication: A case report
by: Arthur Augusto Martins e Silva, et al.
Published: (2025-06-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Vascularised periosteal free flap reconstruction for medication-related osteonecrosis of the jaw: a case series
by: Isabella Reid, et al.
Published: (2022-03-01)

Analysis of prosthetic risk factors for peri-implant medication-related osteonecrosis of the jaw: an observational study
by: Da Young Kim, et al.
Published: (2025-05-01)

Clear Cell Odontogenic Carcinoma of the Mandible Harboring EWSR1 Rearrangement: Report of a Massive Jaw Tumor and Review of Diagnostic Considerations
by: Adepitan A. Owosho, et al.
Published: (2021-01-01)

Osteonecrosis of the jaw associated with ustekinumab in the treatment of Crohn's disease
by: Jean Massaad, et al.
Published: (2024-10-01)

Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw – a scoping review
by: Ghaidaa Badabaan, et al.
Published: (2023-02-01)

Surgical extraction with photobiomodulation as an adjunctive modality in patients at-risk for medication-related osteonecrosis of the jaw: retrospective study
by: Gianluca Tenore, et al.
Published: (2025-04-01)

Effectiveness of Leukocyte- and Platelet-rich Fibrin in the Management of Medication-related Osteonecrosis of the Jaws – A Systematic Review
by: Rahul Mohandas, et al.
Published: (2024-01-01)

Treatment period and changes in bone markers according to the application of teriparatide in treating medication-related osteonecrosis of the jaw
by: Jin Hoo Park, et al.
Published: (2025-04-01)

Determinants of outcome in cancer patients with medication-related osteonecrosis of the jaw: A 19-year retrospective study
by: Jenna Ward, et al.
Published: (2024-06-01)

Photobiomodulation in Medication-Related Osteonecrosis of the Jaw: Outcomes in Stage I and Its Adjunctive Role in Advanced Cases
by: Filip Michalak, et al.
Published: (2025-04-01)

Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw
by: Giuliano Ascani, et al.
Published: (2014-01-01)

Comprehensive Approach to the Treatment and Prevention of Bisphosphonate-Induced Osteonecrosis of the Jaw
by: Pilipov, I.A., et al.
Published: (2025-04-01)

How does medication-related osteonecrosis of the jaw (MRONJ) influence the health-related quality of life after surgery?
by: Oliver Bissinger, et al.
Published: (2025-06-01)

The issue with incidence: a scoping review of reported medication-related osteonecrosis of the jaws (MRONJ) incidence around the globe
by: Anne-Marie Glenny, et al.
Published: (2025-05-01)

Medication-Related Osteonecrosis of Jaws: A Low-Level Laser Therapy and Antimicrobial Photodynamic Therapy Case Approach
by: Mariana Comparotto Minamisako, et al.
Published: (2016-01-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
by: Raed AlRowis, et al.
Published: (2022-03-01)

Neuralgia Inducing Cavitational Osteonecrosis of the Jaw: Scientific Controversy or pseudoscience?
by: Keith DA
Published: (2025-08-01)

Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw
by: Thainara Alexia Marinho de Souza, et al.
Published: (2024-04-01)

A case series and review of canine idiopathic osteonecrosis of the jaw
by: Amy Rossi, et al.
Published: (2025-05-01)